These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Martin SR; Atkison P; Anand R; Lindblad AS; Pediatr Transplant; 2004 Jun; 8(3):273-83. PubMed ID: 15176966 [TBL] [Abstract][Full Text] [Related]
4. Trends of Immunosuppression and Outcomes Following Liver Transplantation: An Analysis of the United Network for Organ Sharing Registry. Cheng EY; Everly MJ Clin Transpl; 2014; ():13-26. PubMed ID: 26281123 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and liver transplantation: a review and guide to management. Watt KD; Charlton MR J Hepatol; 2010 Jul; 53(1):199-206. PubMed ID: 20451282 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk, atherosclerosis and metabolic syndrome after liver transplantation: a mini review. Oliveira CP; Stefano JT; Alvares-da-Silva MR Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):361-4. PubMed ID: 23639094 [TBL] [Abstract][Full Text] [Related]
7. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Charlton M; Seaberg E Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024 [TBL] [Abstract][Full Text] [Related]
8. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance. Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N Clin Transpl; 2011; ():223-35. PubMed ID: 22755416 [TBL] [Abstract][Full Text] [Related]
9. Long-term survival and late graft loss in pediatric liver transplant recipients--a 15-year single-center experience. Wallot MA; Mathot M; Janssen M; Hölter T; Paul K; Buts JP; Reding R; Otte JB; Sokal EM Liver Transpl; 2002 Jul; 8(7):615-22. PubMed ID: 12089716 [TBL] [Abstract][Full Text] [Related]
11. Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors. Tinti F; Mitterhofer AP; Muiesan P Minerva Chir; 2012 Feb; 67(1):1-13. PubMed ID: 22361672 [TBL] [Abstract][Full Text] [Related]
12. MELD and prediction of post-liver transplantation survival. Habib S; Berk B; Chang CC; Demetris AJ; Fontes P; Dvorchik I; Eghtesad B; Marcos A; Shakil AO Liver Transpl; 2006 Mar; 12(3):440-7. PubMed ID: 16498643 [TBL] [Abstract][Full Text] [Related]
13. Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C. Hibi T; Nishida S; Sageshima J; Levi DM; Ruiz P; Roth D; Martin P; Okabayashi K; Burke GW; Ciancio G; Tzakis AG Transpl Int; 2014 Jun; 27(6):606-16. PubMed ID: 24606223 [TBL] [Abstract][Full Text] [Related]
14. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma. Suh MY; Wang K; Gutweiler JR; Misra MV; Krawczuk LE; Jenkins RL; Lillehei CW; Jonas MM; Kim HB J Pediatr Surg; 2008 Jun; 43(6):1148-52. PubMed ID: 18558198 [TBL] [Abstract][Full Text] [Related]
15. Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid. Uemura T; Schaefer E; Hollenbeak CS; Khan A; Kadry Z Transpl Int; 2011 Jul; 24(7):640-50. PubMed ID: 21429047 [TBL] [Abstract][Full Text] [Related]
16. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Charlton M; Levitsky J; Aqel B; OʼGrady J; Hemibach J; Rinella M; Fung J; Ghabril M; Thomason R; Burra P; Little EC; Berenguer M; Shaked A; Trotter J; Roberts J; Rodriguez-Davalos M; Rela M; Pomfret E; Heyrend C; Gallegos-Orozco J; Saliba F Transplantation; 2018 May; 102(5):727-743. PubMed ID: 29485508 [TBL] [Abstract][Full Text] [Related]
17. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients. Meadows HB; Taber DJ; Pilch NA; Tischer SM; Baliga PK; Chavin KD Transplant Proc; 2012 Jun; 44(5):1323-8. PubMed ID: 22664009 [TBL] [Abstract][Full Text] [Related]
18. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network. Smith CM; Davies DB; McBride MA Clin Transpl; 2000; ():19-30. PubMed ID: 11512312 [TBL] [Abstract][Full Text] [Related]
19. The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection. Neff GW; Shire N; Ruiz P; O'Brien C; Garcia M; Dela Garza J; Rudich SR; Reddy KR Transplant Proc; 2005 Dec; 37(10):4397-402. PubMed ID: 16387130 [TBL] [Abstract][Full Text] [Related]
20. Liver transplantation at the University of Chicago. Millis JM; Alonso EM; Piper JB; Bruce DS; Newell KA; Woodle ES; Baker AL; Whitington PF; Thistlethwaite JR Clin Transpl; 1995; ():187-97. PubMed ID: 8794265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]